echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > A new mechanism for the steady-state regulation of hematopoietic stem cells has been revealed

    A new mechanism for the steady-state regulation of hematopoietic stem cells has been revealed

    • Last Update: 2020-12-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The Wang Jinyong Group of the Guangzhou Institute of Biomedicine and Health of the Chinese Academy of Sciences and the National Key Laboratory of Experimental Hematology of the Chinese Academy of Medical Sciences, Cheng Hui/Cheng Tao, collaborated to make a new breakthrough in the field of steady-state regulation of hematopoietic stem cells. The study was published online in Hematology. It is reported that Wang Tongjie, Xia Chengxiang as the article's co-first author, Wang Jinyong and Cheng Hui as the co-communications author.
    hematopoietic stem cells (HSCs) have the ability to renew themselves and differentiate into a variety of blood cells. Physiologically, HSC is mostly dormant, with only a small number of cells proliferating to maintain hematostation. In some stress states (e.g. excessive blood loss, radiation damage, chemotherapy, etc.), HSC can quickly activate from the sleep state for blood production, when the body returns to normal state, HSC will re-enter the sleep state. This kind of precise steady state maintenance is regulated by complex mechanism, so far, the balance control mechanism between HSC sleep state and active state is not clear.
    study found that
    expression levels of the gene in HSC were significantly higher than those of hematocytes. To study
    role of the disease in HSC, the
    model of a mouse that was subject to a conditional knock-out. It was found that the missing HSC of
    entered the cell cycle more in physiological steady state, and the competitive transplantation experiment showed that Nupr1-/- HSC had transplant competitive advantage in the body, and the in vitro amplification experiment also showed that Nupr1-/- HSC had stronger proliferation ability.
    further transcription group sequencing results reveal that the
    The p53 signal path of the HSC is significantly reduced, followed by a correction of the p53 expression level in the
    HSC, which reduces its competitive advantage, indicating that the
    's steady state adjustment to the HSC is achieved through the p53 signal path. This study is of great theoretical significance for seeking means to intervene in HSC amplification, dry maintenance and promoting implantation.
    The study found that transcription factor
    regulates the conversion of HSC sleep state and activation state through p53 signal path, knocks out the HSC of
    more in the proliferation period and has a stronger transplant competitive advantage, this discovery reveals the new mechanism of HSC steady state regulation. (Source: China Science Journal Zhu Hanbin Huang Boquan)
    related paper information:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.